Literature DB >> 30022448

Silibinin ameliorates amylin-induced pancreatic β-cell apoptosis partly via upregulation of GLP-1R/PKA pathway.

Jing Yang1, Yue Sun1, Fanxing Xu1, Weiwei Liu1, Yingsi Mai1, Toshihiko Hayashi1,2, Shunji Hattori3, Yuko Ushiki-Kaku3, Satoshi Onodera4, Shin-Ichi Tashiro5, Takashi Ikejima6.   

Abstract

The objective was to investigate the mechanism of the protective effect of silibinin on amylin/Aβ1-42-induced INS-1 cell apoptosis, with special reference to the roles of glucagon-like peptide-1 receptor (GLP-1R) and protein kinase A (PKA). The effects of silibinin on apoptosis, insulin secretion, GLP-1R, and PKA expression in the INS-1 cells treated with amylin/Aβ1-42 were examined. INS-1 cells exposed to amylin showed increased TUNEL-positive ratio, reduced expression of GLP-1R and PKA. GLP-1R antagonists or PKA inhibitor enhanced the expression of apoptosis-associated proteins and TUNEL-positive ratio. Silibinin exerted antiapoptotic effect on and upregulation of GLP-1R and PKA. However, Aβ1-42-induced INS-1 cell apoptosis, GLP-1R, and PKA expressions were not changed. Our results indicate that down-regulation of GLP-1R and PKA contributes to INS-1 cell apoptosis induced with amylin. Silibinin protects INS-1 cells from amylin-induced apoptosis through activation of GLP-1R/PKA signaling. Silibinin's inhibition of the toxic effects of Aβ1-42 is independent of GLP-1R/PKA pathway.

Entities:  

Keywords:  Apoptosis; GLP-1R; INS-1 cells; PKA; Silibinin

Mesh:

Substances:

Year:  2018        PMID: 30022448     DOI: 10.1007/s11010-018-3414-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  4 in total

1.  Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway.

Authors:  Wei-Wei Liu; Fang Wang; Can Li; Xiao-Yu Song; Wuxiyar Otkur; Yu-Ying Zhu; Toshihiko Hayashi; Kazunori Mizuno; Shunji Hattori; Hitomi Fujisaki; Takashi Ikejima
Journal:  Acta Pharmacol Sin       Date:  2021-12-15       Impact factor: 7.169

Review 2.  Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.

Authors:  Maryam Fallah; Amirhossein Davoodvandi; Shahin Nikmanzar; Sarehnaz Aghili; Seyed Mohammad Ali Mirazimi; Michael Aschner; Amir Rashidian; Michael R Hamblin; Mohsen Chamanara; Navid Naghsh; Hamed Mirzaei
Journal:  Biomed Pharmacother       Date:  2021-08-13       Impact factor: 6.529

Review 3.  Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus.

Authors:  Pratiksha H Roham; Shreyada N Save; Shilpy Sharma
Journal:  J Pharm Anal       Date:  2022-04-07

Review 4.  Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease.

Authors:  Ana F Raimundo; Sofia Ferreira; Ivo C Martins; Regina Menezes
Journal:  Front Mol Neurosci       Date:  2020-03-20       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.